Biochem/physiol Actions
KT182 is a very potent, orally bioavailable, selective inhibitor of ABHD6 (a/b-Hydrolase Domain Containing 6). IC50 = 1.7 nM. KT182 inhibits ABHD6 activity in the brain and liverin mice (ip administration).
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: